Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions


Phase 2 Results N/A

Summary of Purpose

Dexmedetomidine is a unique sedative medication able to provide sedation without causing respiratory depression and maintaining neurological functions. Patients having an acute ischemic stroke and need to undergo endovascular therapy require constant assessment of their neurological status prior, during and after the interventional procedure. In this study the investigators will compare the efficacy of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2013.

1 Apr 2012 29 Apr 2013 1 Dec 2013 1 Dec 2013 1 Apr 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Outcomes Assessor)
  • Purpose: Supportive Care
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment